Does Second Trimester Maternal Serum Zonulin Level Predict Gestational Diabetes Mellitus?

Area of Science:

• Endocrinology
• Gastroenterology
• Biomarker Discovery

Background:

• Zonulin regulates intestinal permeability and is implicated in various diseases.
• Gestational diabetes mellitus (GDM) is a common pregnancy complication.
• The role of zonulin as a potential biomarker for GDM requires further investigation.

Purpose of the Study:

• To compare plasma zonulin levels between GDM patients and controls.
• To explore differences in zonulin levels based on GDM treatment (diet vs. insulin).
• To assess zonulin's potential as a non-invasive biomarker for GDM.

Main Methods:

• Study included 90 pregnant women (24-28 weeks gestation).
• Gestational diabetes mellitus diagnosed via Oral Glucose Tolerance Test (OGTT) per ADA standards.
• Plasma zonulin levels measured using Enzyme-Linked Immunosorbent Assay (ELISA).

Main Results:

• GDM patients exhibited significantly higher plasma zonulin levels compared to controls (p < 0.005).
• Preliminary findings suggest a correlation between GDM and elevated zonulin.
• Further research is needed to confirm zonulin's role and clinical utility.

Conclusions:

• Plasma zonulin levels are significantly elevated in women with GDM.
• Zonulin may serve as a potential non-invasive biomarker in the etiology of GDM.
• Larger studies are warranted to validate these findings and explore therapeutic implications.